Clinical Pharmacy Specialist-Lymphoma @MSKCancerCenter 🧬🩸💊| BCOP | Cancer survivor🎗
New York, USA
Joined November 2011
- Tweets3.5K
- Following379
- Followers482
- Likes2.1K
Lynnette Henshaw, PharmD, BCOP retweeted
🔥🔥🔥🔥🔥 Nivo-AVD is here to stay
nejm.org/doi/full/10.1056/NE…
My Cycle for survival ride is almost here, please consider donating if you haven’t already! 🚴🏼♀️🎗️
secure2.convio.net/mskcc/sit… – at New York, NY
Please donate to my team! @Cycle4Survival and raise money for rare cancer research at @MSKCancerCenter. You can help build a better future for people worldwide. secure2.convio.net/mskcc/sit…
🥹🥹So glad to have these girls by my side in Boston for the last 3 years 🩷🩷 – at Boston, MA
Just like that I’m (almost) the last 2021 BMCPharmRes standing!!! We will miss you @lynnalidomide 🥹💕
Lynnette Henshaw, PharmD, BCOP retweeted
🔬💊 Happening Now: The #AmyloidosisForum will consider how to effectively design #ATTR #amyloidosis trials as the first generation of drug approvals have reshaped the research landscape.
Join us and 60+ speakers all day today: us02web.zoom.us/webinar/regi… – at White Oak, MD
Lynnette Henshaw, PharmD, BCOP retweeted
If you are wondering how Belantamab Mafodotin did in real world, check out our systematic review article @japacademy @UAMSMyeloma
#mmsm
➡️journal.japacademy.org/index… – at Miramar Beach, FL
🔬 Unveiling the real-world use of Belantamab Mafodotin in relapsed/refractory multiple myeloma! Dive into our systematic review to explore the efficacy and safety of this antibody drug conjugate. Stay informed with the latest findings.
#MultipleMyelomaTreatment #JAPAJournal
Lynnette Henshaw, PharmD, BCOP retweeted
Ongoing & future trials for #ATTR #amyloidosis drugs face challenges their predecessors didn't. Access to new treatments is getting more complex.
Next week's #AmyloidosisForum will discuss these and other problems & solutions in ATTR drug development: amyloidosisforum.org/attr-dr…
ALT Session 10 at the Amyloidosis Forum on June 21, 2023 will be Moderated by Mathew S. Maurer, MD, Presnted by Sharmila Dorbala, MD, MPH, MASNC, and Dhruve Kazi, MD, MSc, MS, and Discussed by Ahmad Masri, MD, MS, Dalia Dawoud, PhD, Francesca Cunningham, PharmD, Lynnette Henshaw, PharmD, BCOP, Megan Azzarone, PharmD, Martin Cowie, MD, and Shari Ling, MD.
So proud of our residents for all their hard work on this QI initiative ! Expanding access to care 🏥💊and decreasing time off cancer therapy due to HTN 📉#oncopharm #twitteRx #proudmentor – at Boston, MA
Congratulations to @sitarabine and @jessica_hodgen for the first place poster @MAPharmacists #MASHP23 annual meeting! Excellent project expanding the pharmacists scope, enhancing patient safety and access to oncologic therapies! #PharmRes #TwitteRx
Lynnette Henshaw, PharmD, BCOP retweeted
Congratulations to @sitarabine and @jessica_hodgen for the first place poster @MAPharmacists #MASHP23 annual meeting! Excellent project expanding the pharmacists scope, enhancing patient safety and access to oncologic therapies! #PharmRes #TwitteRx
Lynnette Henshaw, PharmD, BCOP retweeted
Pola+R-CHP approved for upfront DLBCL. However, no improvement in OS or QOL compared to standard R-CHOP. We’re talking about a 6.5% absolute difference in 2-year PFS here with a major increase in cost. This is a marginal gain, not a game changer 🤷🏻♂️ #lymsm onclive.com/view/fda-approve…
Lynnette Henshaw, PharmD, BCOP retweeted
Just a reminder that you can do everything “right” and unfortunately still get cancer. Never blame or shame someone dealing with a cancer diagnosis.
Lynnette Henshaw, PharmD, BCOP retweeted
⚠️ so many reasons not to do this
anticholinergic toxicity is NO joke!
….anyone have physo?! I’ve never seen it used!
any pearls from #toxtwitter #MedTwitter #TwitteRx ?
Lynnette Henshaw, PharmD, BCOP retweeted
Had a great time at #HOPAAC23 with some of my favorite people! – at Phoenix, AZ
Had a great time presenting my research at the poster session last night @HOPArx #HOPAAC23 #oncopharm #twitterx – at Phoenix, AZ
Lynnette Henshaw, PharmD, BCOP retweeted
Very proud of @sitarabine for presenting our QIP at #HOPAAC23 on Optimizing the Management of Prostate Cancer Treatment-Related HTN 🫀in a highly underserved patient population! Also awarded 1 of 5 Quality in Oncology Care certificates 🏅#HOPA2023 @BMCPharmRes @The_BMC
Very honored to speak at #hopa2023 today 👩🏼⚕️💊 shout out to @CamilleVEdwards for her help in putting together this project! 🩸Excited to see what the rest of the conference holds @HOPArx #twitterx #oncopharm
Lynnette Henshaw, PharmD, BCOP retweeted
Another first timer presentation at #HOPAAC23 ! Proud mentor moment for a past resident and now friend 🥲#TwitteRx #oncopharm @lynnettehenshaw
Our PGY-2 oncology pharmacy residency is entering phase 2 of the match, we have 1 open spot 💊🩸
If you or anyone you know is interested you can reach out directly to myself or @JPatel_PharmD via direct message or email
More info on our website
bmc.org/pharmacy-residency/p… #twitteRx – at Boston, MA
Boston Medical Center has a few programs entering Phase II
Be sure to check us out if your interested in:
- Oncology (carT, gene therapy, Outpatient mng)
-IM (TOC, unique pop, SUD)
-1/2 HSPAL +MS (system opportunity in compact & adaptable sys)
Www.bmc.org/PharmacyResidenc…
Lynnette Henshaw, PharmD, BCOP retweeted
Boston Medical Center has a few programs entering Phase II
Be sure to check us out if your interested in:
- Oncology (carT, gene therapy, Outpatient mng)
-IM (TOC, unique pop, SUD)
-1/2 HSPAL +MS (system opportunity in compact & adaptable sys)
Www.bmc.org/PharmacyResidenc…